BWA
46
2
EXC
56
2
ADSK
68
2
URBN
42
4
SO
57
2
DTE
54
4
ISRG
76
2
CMCSA
52
4
FLR
55
6
MCD
50
-2
HBAN
56
2
EW
39
2
HBI
55
-4
MMC
60
6
FTI
76
3
BAX
30
4
KMI
69
2
OMC
61
6
BK
72
4
MCO
75
2
BWA
46
2
EXC
56
2
ADSK
68
2
URBN
42
4
SO
57
2
DTE
54
4
ISRG
76
2
CMCSA
52
4
FLR
55
6
MCD
50
-2
HBAN
56
2
EW
39
2
HBI
55
-4
MMC
60
6
FTI
76
3
BAX
30
4
KMI
69
2
OMC
61
6
BK
72
4
MCO
75
2
Financhill
Back

Catalyst Pharmaceuticals Vs. Target Industry Stock Comparison

Sell
46

CPRX
Catalyst Pharmaceuticals

Last Price:
21.13
Seasonality Move:
4.48%
Sell
20

TGT
Target

Last Price:
121.59
Seasonality Move:
4.08%
Sell
46
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $21.12. The Score for CPRX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Target (TGT) is a Sell

Is Target a Buy, Sell or Hold?

  • The current Target [TGT] share price is $121.59. The Score for TGT is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • TGT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $21.12
    The current trend is moderately bearish and CPRX is experiencing slight buying pressure.

TGT Stock Price Chart

What is Target's stock price today?

  • The Target share price today is $121.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TGT is experiencing slight selling pressure.

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 45.27 Sell
Chaikin Money Flow: 380001 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.02 - 22.7) Sell
Bollinger Bands (100): (17.53 - 21.69) Buy

TGT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.85 Sell
Relative Strength Index (14 RSI): 23.91 Sell
Chaikin Money Flow: -8404826 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (140.56 - 157.62) Sell
Bollinger Bands (100): (142.35 - 156.95) Sell

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.58 Sell
20-day SMA: 22 Sell
50-day SMA: 21.09 Buy
200-day SMA: 17.53 Buy
8-day EMA: 21.5 Sell
20-day EMA: 21.69 Sell
50-day EMA: 21.05 Buy
200-day EMA: 18.22 Buy

TGT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 146.51 Sell
20-day SMA: 148.61 Sell
50-day SMA: 151.64 Sell
200-day SMA: 153.85 Sell
8-day EMA: 141.24 Sell
20-day EMA: 147.16 Sell
50-day EMA: 149.8 Sell
200-day EMA: 149.63 Sell

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.05 per share.

Target Earnings Growth & TGT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.33 per share, an increase this year of $2.81 per share, and an increase next year of $0.38 per share.

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Target Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):